News

05 Mar Nordion Launches a New and Improved TheraSphere(R) Website to Meet the Needs of Liver Cancer Physicians, Patients and Caregivers Worldwide

TheraSphere.com provides unique resources and targeted information about this innovative radioembolization therapy

OTTAWA, Ontario–(BUSINESS WIRE)–Mar. 5, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today that it has launched a new and improved, intuitive, feature-rich TheraSphere® website, providing liver cancer patients and physicians with customized TheraSphere® resources that include medical and clinical information, convenient online ordering, and innovative digital resources…

28 Jan Nordion Appoints Mr. Grant Gardiner as SVP and General Counsel

OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 28, 2013 — Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it is appointing Grant Gardiner as Senior Vice President, General Counsel & Corporate Secretary. Mr. Gardiner will serve as the Corporation’s legal officer responsible for all global legal matters, effective March 18, 2013…

24 Jan Nordion, Manufacturer of TheraSphere(R), to Host Educational Symposium at the 2013 Gastrointestinal Cancers Symposium

Agenda includes new HCC clinical data and an update on TheraSphere® Phase III clinical trials OTTAWA, Ontario–(BUSINESS WIRE)–Jan. 24, 2013– Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services for the prevention, diagnosis and treatment of disease, announced today it is hosting…